{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:06:56Z","timestamp":1782940016433,"version":"3.54.5"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003484","name":"Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003484","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The RUNX1\/ETO fusion protein is a chimeric transcription factor in acute myeloid leukemia (AML) created by chromosomal translocation t(8;21)(q22;q22). t(8;21) abnormality is associated with 12% of <jats:italic>de novo<\/jats:italic> AML cases and up to 40% in the AML subtype M2. Previously, we identified the small-molecule inhibitor <jats:bold>7.44<\/jats:bold>, which interferes with NHR2 domain tetramerization of RUNX1\/ETO, restores gene expression down-regulated by RUNX1\/ETO, inhibits proliferation, and reduces RUNX1\/ETO-related tumor growth in a mouse model. However, despite favorable properties, <jats:bold>7.44<\/jats:bold> is negatively charged at physiological pH and was predicted to have low to medium membrane permeability. Here, we identified <jats:bold>M23<\/jats:bold>, <jats:bold>M27<\/jats:bold>, and <jats:bold>M10<\/jats:bold> as non-charged analogs of <jats:bold>7.44<\/jats:bold> using ligand-based virtual screening, in vivo hit identification, biophysical and in vivo hit validation, and integrative modeling and ADMET predictions. All three compounds interact with the NHR2 domain, have <jats:italic>K<\/jats:italic>\n            <jats:sub>D, app<\/jats:sub> values of 39\u2013114 \u00b5M in Microscale Thermophoresis experiments, and <jats:italic>IC<\/jats:italic>\n            <jats:sub>50<\/jats:sub> values of 33\u201377 \u00b5M as to cell viability in RUNX1\/ETO-positive KASUMI cells, i.e., are ~\u20095 to 10-fold more potent than <jats:bold>7.44<\/jats:bold>. <jats:bold>M23<\/jats:bold> is ~\u200910-fold more potent than <jats:bold>7.44<\/jats:bold> in inhibiting cell proliferation of RUNX1\/ETO-positive cells. Biological characterization of <jats:bold>M23<\/jats:bold> in relevant RUNX1\/ETO-positive -and negative cell lines indicates that <jats:bold>M23<\/jats:bold> induces apoptosis and promotes differentiation in RUNX1\/ETO-positive AML cells. <jats:bold>M23<\/jats:bold> and <jats:bold>M27<\/jats:bold> are negligibly protonated or in a\u2009~\u20091:1 ratio at physiological pH, while <jats:bold>M10<\/jats:bold> has no (de-)protonatable group. The non-protonated species are predicted to be highly membrane-permeable, along with other favorable pharmacokinetic and toxicological properties. These compounds might serve as lead structures for compounds inhibiting RUNX1\/ETO oncogenic function in t(8;21) AML.<\/jats:p>","DOI":"10.1038\/s41598-025-02422-z","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T22:31:14Z","timestamp":1747866674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of non-charged 7.44 analogs interacting with the NHR2 domain of RUNX1-ETO with improved antiproliferative effect in RUNX-ETO positive cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Mohanraj","family":"Gopalswamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0332-8338","authenticated-orcid":false,"given":"David","family":"Bickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0871-9165","authenticated-orcid":false,"given":"Niklas","family":"Dienstbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Wey","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0735-1404","authenticated-orcid":false,"given":"Stephan","family":"Schott-Verdugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6494-7744","authenticated-orcid":false,"given":"Sanil","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9796-3246","authenticated-orcid":false,"given":"Manuel","family":"Etzkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8613-1447","authenticated-orcid":false,"given":"Holger","family":"Gohlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"2422_CR1","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1038\/sj.onc.1207727","volume":"23","author":"LF Peterson","year":"2004","unstructured":"Peterson, L. F. & Zhang, D. E. The 8; 21 translocation in leukemogenesis. Oncogene 23, 4255\u20134262 (2004).","journal-title":"Oncogene"},{"key":"2422_CR2","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1182\/blood.V91.9.3134","volume":"91","author":"T Okuda","year":"1998","unstructured":"Okuda, T. et al. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood 91, 3134\u20133143 (1998).","journal-title":"Blood"},{"key":"2422_CR3","doi-asserted-by":"crossref","unstructured":"Reikvam, H., Hatfield, K. J., Kittang, A. O., Hovland, R. & Bruserud, O. Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications. J. Biomed. Biotechnol. 2011, 104631 (2011).","DOI":"10.1155\/2011\/104631"},{"key":"2422_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14789450.2020.1717951","volume":"17","author":"AD van Dijk","year":"2020","unstructured":"van Dijk, A. D., de Bont, E. & Kornblau, S. M. Targeted therapy in acute myeloid leukemia: Current status and new insights from a proteomic perspective. Expert Rev. Proteom. 17, 1\u201310 (2020).","journal-title":"Expert Rev. Proteom."},{"key":"2422_CR5","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H Dohner","year":"2015","unstructured":"Dohner, H., Weisdorf, D. J. & Bloomfield, C. D. Acute myeloid leukemia. N Engl. J. Med. 373, 1136\u20131152 (2015).","journal-title":"N Engl. J. Med."},{"key":"2422_CR6","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1200\/JCO.2005.15.610","volume":"23","author":"G Marcucci","year":"2005","unstructured":"Marcucci, G. et al. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): A cancer and leukemia group B study. J. Clin. Oncol. 23, 5705\u20135717 (2005).","journal-title":"J. Clin. Oncol."},{"key":"2422_CR7","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.6004\/jnccn.2013.0176","volume":"11","author":"J Kim","year":"2013","unstructured":"Kim, J. & Hurria, A. Determining chemotherapy tolerance in older patients with cancer. J. Natl. Compr. Canc Netw. 11, 1494\u20131502 (2013).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"2422_CR8","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/bjh.17746","volume":"196","author":"S Kayser","year":"2022","unstructured":"Kayser, S. & Levis, M. J. Updates on targeted therapies for acute myeloid leukaemia. Br. J. Haematol. 196, 316\u2013328 (2022).","journal-title":"Br. J. Haematol."},{"key":"2422_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/1568009616666151113120146","volume":"16","author":"R Arora","year":"2016","unstructured":"Arora, R., Sawney, S. & Saluja, D. Potential therapeutic approaches for the treatment of acute myeloid leukemia with AML1-ETO translocation. Curr. Cancer Drug Targets 16, 215\u2013225 (2016).","journal-title":"Curr. Cancer Drug Targets"},{"key":"2422_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ccr.2006.03.012","volume":"9","author":"Y Liu","year":"2006","unstructured":"Liu, Y. et al. The tetramer structure of the nervy homology two domain, NHR2, is critical for AML1\/ETO\u2019s activity. Cancer Cell. 9, 249\u2013260 (2006).","journal-title":"Cancer Cell."},{"key":"2422_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nature12287","volume":"500","author":"XJ Sun","year":"2013","unstructured":"Sun, X. J. et al. A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis. Nature 500, 93\u2013U120 (2013).","journal-title":"Nature"},{"key":"2422_CR12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1128\/MCB.21.1.156-163.2001","volume":"21","author":"JS Zhang","year":"2001","unstructured":"Zhang, J. S. et al. Oligomerization of ETO is obligatory for corepressor interaction. Mol. Cell. Biol. 21, 156\u2013163 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"2422_CR13","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/leu.2009.288","volume":"24","author":"D Mannari","year":"2010","unstructured":"Mannari, D., Gascoyne, D., Dunne, J., Chaplin, T. & Young, B. A novel exon in AML1-ETO negatively influences the clonogenic potential of the t(8;21) in acute myeloid leukemia. Leukemia 24, 891\u2013894 (2010).","journal-title":"Leukemia"},{"key":"2422_CR14","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.1038\/s41388-021-01952-w","volume":"40","author":"K Rejeski","year":"2021","unstructured":"Rejeski, K., Duque-Afonso, J. & Lubbert, M. AML1\/ETO and its function as a regulator of gene transcription via epigenetic mechanisms. Oncogene 40, 5665\u20135676 (2021).","journal-title":"Oncogene"},{"key":"2422_CR15","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1073\/pnas.0810558106","volume":"106","author":"C Kwok","year":"2009","unstructured":"Kwok, C., Zeisig, B. B., Qiu, J. H., Dong, S. O. & So, C. W. E. Transforming activity of AML1-ETO is independent of CBF beta and ETO interaction but requires formation of homo-oligomeric complexes. P Natl. Acad. Sci. USA. 106, 2853\u20132858 (2009).","journal-title":"P Natl. Acad. Sci. USA"},{"key":"2422_CR16","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1021\/ci400332e","volume":"53","author":"A Metz","year":"2013","unstructured":"Metz, A., Schanda, J., Grez, M., Wichmann, C. & Gohlke, H. From determinants of RUNX1\/ETO tetramerization to small-molecule protein-protein interaction inhibitors targeting acute myeloid leukemia. J. Chem. Inf. Model. 53, 2197\u20132202 (2013).","journal-title":"J. Chem. Inf. Model."},{"key":"2422_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1182\/blood-2009-10-248047","volume":"116","author":"C Wichmann","year":"2010","unstructured":"Wichmann, C. et al. Dimer-tetramer transition controls RUNX1\/ETO leukemogenic activity. Blood 116, 603\u2013613 (2010).","journal-title":"Blood"},{"key":"2422_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","volume":"7","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Therapeutic peptides: Current applications and future directions. Signal. Transduct. Target. Ther. 7, 48 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"2422_CR19","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.3324\/haematol.2016.161570","volume":"102","author":"J Schanda","year":"2017","unstructured":"Schanda, J. et al. Suppression of RUNX1\/ETO oncogenic activity by a small molecule inhibitor of tetramerization. Haematologica 102, e170\u2013e174 (2017).","journal-title":"Haematologica"},{"key":"2422_CR20","doi-asserted-by":"publisher","first-page":"14158","DOI":"10.1038\/s41598-022-17913-6","volume":"12","author":"M Gopalswamy","year":"2022","unstructured":"Gopalswamy, M. et al. Biophysical and Pharmacokinetic characterization of a small-molecule inhibitor of RUNX1\/ETO tetramerization with anti-leukemic effects. Sci. Rep. 12, 14158 (2022).","journal-title":"Sci. Rep."},{"key":"2422_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1021\/jm0603365","volume":"50","author":"PCD Hawkins","year":"2007","unstructured":"Hawkins, P. C. D., Skillman, A. G. & Nicholls, A. Comparison of shape-matching and docking as virtual screening tools. J. Med. Chem. 50, 74\u201382 (2007).","journal-title":"J. Med. Chem."},{"key":"2422_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pnmrs.2016.09.001","volume":"97","author":"AD Gossert","year":"2016","unstructured":"Gossert, A. D. & Jahnke, W. NMR in drug discovery: A practical guide to identification and validation of ligands interacting with biological macromolecules. Prog Nucl. Mag Res. Sp  97, 82\u2013125 (2016).","journal-title":"Prog Nucl. Mag Res. Sp"},{"key":"2422_CR23","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1002\/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q","volume":"38","author":"M Mayer","year":"1999","unstructured":"Mayer, M. & Meyer, B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew Chem. Int. Ed.  38, 1784\u20131788 (1999).","journal-title":"Angew Chem. Int. Ed."},{"key":"2422_CR24","first-page":"117","volume":"9","author":"X Zhao","year":"2002","unstructured":"Zhao, X., Ghaffari, S., Lodish, H., Malashkevich, V. N. & Kim, P. S. Structure of the Bcr-Abl oncoprotein oligomerization domain. Nat. Struct. Biol. 9, 117\u2013120 (2002).","journal-title":"Nat. Struct. Biol."},{"key":"2422_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41388-018-0441-7","volume":"38","author":"L Chen-Wichmann","year":"2019","unstructured":"Chen-Wichmann, L. et al. Compatibility of RUNX1\/ETO fusion protein modules driving CD34\u2009+\u2009human progenitor cell expansion. Oncogene 38, 261\u2013272 (2019).","journal-title":"Oncogene"},{"key":"2422_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/pro.3986","volume":"30","author":"V Kotov","year":"2021","unstructured":"Kotov, V. et al. In-depth interrogation of protein thermal unfolding data with moltenprot. Protein Sci. 30, 201\u2013217 (2021).","journal-title":"Protein Sci."},{"key":"2422_CR27","doi-asserted-by":"crossref","unstructured":"Bruce, D., Cardew, E., Freitag-Pohl, S. & Pohl, E. How to stabilize protein: Stability screens for thermal shift assays and nano differential scanning fluorimetry in the virus-X project. Jove-J Vis. Exp. (2019).","DOI":"10.3791\/58666"},{"key":"2422_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/1087057105284218","volume":"11","author":"A Tjernberg","year":"2006","unstructured":"Tjernberg, A., Markova, N., Griffiths, W. J. & Hallen, D. DMSO-related effects in protein characterization. J. Biomol. Screen. 11, 131\u2013137 (2006).","journal-title":"J. Biomol. Screen."},{"key":"2422_CR29","doi-asserted-by":"crossref","unstructured":"Wienken, C. J., Baaske, P., Rothbauer, U., Braun, D. & Duhr, S. Protein-binding assays in biological liquids using microscale thermophoresis. Nat. Commun. 1 (2010).","DOI":"10.1038\/ncomms1093"},{"key":"2422_CR30","doi-asserted-by":"publisher","first-page":"8739","DOI":"10.1021\/acs.jmedchem.5b01114","volume":"58","author":"O Cala","year":"2015","unstructured":"Cala, O. & Krimm, I. Ligand-orientation based fragment selection in STD NMR screening. J. Med. Chem. 58, 8739\u20138742 (2015).","journal-title":"J. Med. Chem."},{"key":"2422_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1182\/blood-2017-10-810986","volume":"132","author":"S Bhatia","year":"2018","unstructured":"Bhatia, S. et al. Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock response. Blood 132, 307\u2013320 (2018).","journal-title":"Blood"},{"key":"2422_CR32","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1021\/ci400370y","volume":"53","author":"H Gohlke","year":"2013","unstructured":"Gohlke, H. et al. Binding region of alanopine dehydrogenase predicted by unbiased molecular dynamics simulations of ligand diffusion. J. Chem. Inf. Model. 53, 2493\u20132498 (2013).","journal-title":"J. Chem. Inf. Model."},{"key":"2422_CR33","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NAP Franken","year":"2006","unstructured":"Franken, N. A. P., Rodermond, H. M., Stap, J., Haveman, J. & van Bree, C. Clonogenic assay of cells in vitro. Nat. Protoc. 1, 2315\u20132319 (2006).","journal-title":"Nat. Protoc."},{"key":"2422_CR34","unstructured":"Perrin, D. D. Dissociation constants of organic bases in aqueous solution. IUPAC Chem. Data Ser., 1\u2013383 (Butterworths, London, 1965)."},{"key":"2422_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ddtec.2004.11.013","volume":"1","author":"M Kansy","year":"2004","unstructured":"Kansy, M., Avdeef, A. & Fischer, H. Advances in screening for membrane permeability: High-resolution PAMPA for medicinal chemists. Drug Discov Today Technol. 1, 349\u2013355 (2004).","journal-title":"Drug Discov Today Technol."},{"key":"2422_CR36","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.1021\/acs.jpcb.7b02914","volume":"121","author":"BJ Bennion","year":"2017","unstructured":"Bennion, B. J. et al. Predicting a drug\u2019s membrane permeability: A computational model validated with in vitro permeability assay data. J. Phys. Chem. B  121, 5228\u20135237 (2017).","journal-title":"J. Phys. Chem. B"},{"key":"2422_CR37","unstructured":"QikProp, S. R. (2023). http:\/\/gohom.win\/ManualHom\/Schrodinger\/Schrodinger_2012_docs\/qikprop\/qikprop_user_manual.pdf (Schr\u00f6dinger, LLC, 2023)."},{"key":"2422_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.addr.2016.05.007","volume":"101","author":"LZ Benet","year":"2016","unstructured":"Benet, L. Z., Hosey, C. M., Ursu, O. & Oprea, T. I. BDDCS, the rule of 5 and drugability. Adv. Drug Deliver Rev. 101, 89\u201398 (2016).","journal-title":"Adv. Drug Deliver Rev."},{"key":"2422_CR39","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","volume":"14","author":"E Lionta","year":"2014","unstructured":"Lionta, E., Spyrou, G., Vassilatis, D. K. & Cournia, Z. Structure-based virtual screening for drug discovery: Principles, applications and recent advances. Curr. Top. Med. Chem. 14, 1923\u20131938 (2014).","journal-title":"Curr. Top. Med. Chem."},{"key":"2422_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.yrtph.2015.12.006","volume":"76","author":"C Barber","year":"2016","unstructured":"Barber, C. et al. Evaluation of a statistics-based ames mutagenicity QSAR model and interpretation of the results obtained. Regul. Toxicol. Pharm. 76, 7\u201320 (2016).","journal-title":"Regul. Toxicol. Pharm."},{"key":"2422_CR41","doi-asserted-by":"crossref","unstructured":"Greene, N., Judson, P. N., Langowski, J. J., and Marchant, C. A. (1999) Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR. SAR QSAR Environ. Res. 10, 299\u2013314.","DOI":"10.1080\/10629369908039182"},{"key":"2422_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj2500001","volume":"250","author":"IH Madshus","year":"1988","unstructured":"Madshus, I. H. Regulation of intracellular pH in eukaryotic cells. Biochem. J. 250, 1\u20138 (1988).","journal-title":"Biochem. J."},{"key":"2422_CR43","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1038\/leu.2015.146","volume":"29","author":"S Bhatia","year":"2015","unstructured":"Bhatia, S. et al. Control of AC133\/CD133 and impact on human hematopoietic progenitor cells through nucleolin. Leukemia 29, 2208\u20132220 (2015).","journal-title":"Leukemia"},{"key":"2422_CR44","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1021\/ed200433z","volume":"89","author":"AD Gift","year":"2012","unstructured":"Gift, A. D., Stewart, S. M. & Bokashanga, P. K. Experimental determination of pK(a) values by use of NMR chemical shifts, revisited. J. Chem. Educ. 89, 1458\u20131460 (2012).","journal-title":"J. Chem. Educ."},{"key":"2422_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"JJ Irwin","year":"2005","unstructured":"Irwin, J. J. & Shoichet, B. K. ZINC\u2013a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model. 45, 177\u2013182 (2005).","journal-title":"J. Chem. Inf. Model."},{"key":"2422_CR46","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1021\/acs.jcim.2c00644","volume":"62","author":"D Petrovic","year":"2022","unstructured":"Petrovic, D. et al. Virtual screening in the cloud identifies potent and selective ROS1 kinase inhibitors. J. Chem. Inf. Model. 62, 3832\u20133843 (2022).","journal-title":"J. Chem. Inf. Model."},{"key":"2422_CR47","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1021\/jm040163o","volume":"48","author":"TS Rush 3rd","year":"2005","unstructured":"Rush, T. S. 3rd, Grant, J. A., Mosyak, L. & Nicholls, A. A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. J. Med. Chem. 48, 1489\u20131495 (2005).","journal-title":"J. Med. Chem."},{"key":"2422_CR48","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1002\/j.1460-2075.1993.tb05933.x","volume":"12","author":"H Miyoshi","year":"1993","unstructured":"Miyoshi, H. et al. The t (8; 21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J. 12, 2715\u20132721 (1993).","journal-title":"EMBO J."},{"key":"2422_CR49","unstructured":"Schr\u00f6dinger Release 2018-1: Maestro. (Schr\u00f6dinger, LLC, New York, NY, 2018)."},{"key":"2422_CR50","doi-asserted-by":"publisher","first-page":"10269","DOI":"10.1021\/j100142a004","volume":"97","author":"CI Bayly","year":"1993","unstructured":"Bayly, C. I., Cieplak, P., Cornell, W. & Kollman, P. A. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: The RESP model. J. Phys. Chem. 97, 10269\u201310280 (1993).","journal-title":"J. Phys. Chem."},{"key":"2422_CR51","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"JM Wang","year":"2004","unstructured":"Wang, J. M., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of a general amber force field. J. Comput. Chem. 25, 1157\u20131174 (2004).","journal-title":"J. Comput. Chem."},{"key":"2422_CR52","unstructured":"Case, D. A. et al. Xiao, L., York, D. M., and P. A. AMBER 2018 (University of California, San Francisco, 2018)."},{"key":"2422_CR53","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier, J. A. et al. ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696\u20133713 (2015).","journal-title":"J. Chem. Theory Comput."},{"key":"2422_CR54","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1002\/jcc.21224","volume":"30","author":"L Martinez","year":"2009","unstructured":"Martinez, L., Andrade, R., Birgin, E. G. & Martinez, J. M. PACKMOL: A package for building initial configurations for molecular dynamics simulations. J. Comput. Chem. 30, 2157\u20132164 (2009).","journal-title":"J. Comput. Chem."},{"key":"2422_CR55","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"2422_CR56","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1021\/ct400314y","volume":"9","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer, R., G\u00f6tz, A. W., Poole, D., Le Grand, S. & Walker, R. C. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald. J. Chem. Theory Comput. 9, 3878\u20133888 (2013).","journal-title":"J. Chem. Theory Comput."},{"key":"2422_CR57","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cpc.2012.09.022","volume":"184","author":"S Le Grand","year":"2013","unstructured":"Le Grand, S., Gotz, A. W. & Walker, R. C. SPFP: Speed without compromise\u2014a mixed precision model for GPU accelerated molecular dynamics simulations. Comput. Phys. Commun. 184, 374\u2013380 (2013).","journal-title":"Comput. Phys. Commun."},{"key":"2422_CR58","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1080\/00268978800101881","volume":"65","author":"RW Pastor","year":"1988","unstructured":"Pastor, R. W., Brooks, B. R. & Szabo, A. An analysis of the accuracy of Langevin and molecular-dynamics algorithms. Mol. Phys. 65, 1409\u20131419 (1988).","journal-title":"Mol. Phys."},{"key":"2422_CR59","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1984","unstructured":"Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684\u20133690 (1984).","journal-title":"J. Chem. Phys."},{"key":"2422_CR60","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"JP Ryckaert","year":"1977","unstructured":"Ryckaert, J. P., Ciccotti, G. & Berendsen, H. J. C. Numerical-integration of cartesian equations of motion of a system with constraints-molecular-dynamics of N-alkanes. J. Comput. Phys. 23, 327\u2013341 (1977).","journal-title":"J. Comput. Phys."},{"key":"2422_CR61","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1021\/ct5010406","volume":"11","author":"CW Hopkins","year":"2015","unstructured":"Hopkins, C. W., Le Grand, S., Walker, R. C. & Roitberg, A. E. Long-time-step molecular dynamics through hydrogen mass repartitioning. J. Chem. Theory Comput. 11, 1864\u20131874 (2015).","journal-title":"J. Chem. Theory Comput."},{"key":"2422_CR62","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe, D. R., Cheatham, T. E. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theory Comput. 9, 3084\u20133095 (2013).","journal-title":"J. Chem. Theory Comput."},{"key":"2422_CR63","unstructured":"Case, D. A. et al. Software of Amber and AmberTools. AMBER 2020 (University of California, San Francisco, 2020)."},{"key":"2422_CR64","unstructured":"PyMOL. The PyMOL Molecular Graphics System. 2.1.0 Ed., Schr\u00f6dinger, LLC."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02422-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02422-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02422-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T11:03:34Z","timestamp":1747911814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02422-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2422"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02422-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"31 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declare no competing interests except that HG is a coauthor on the patent EP\/30.04.13\/EPA 13165993, 2014.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17720"}}